Neologics Bioscience - Crunchbase Company Profile & Funding

Q: Where is Neologics Bioscience's headquarters?

Neologics Bioscience is located in Suzhou, Jiangsu, China.

Q: How much funding has Neologics Bioscience raised to date?

Neologics Bioscience has raised obfuscated.

Overview

Neologics Bioscience

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Neologics Bioscience

CB Rank

129911

Neologics Bioscience develops antibody-based therapeutics for cancer and autoimmune diseases.

Founded

obfuscation

Private

Corporate Round

Suzhou, Jiangsu, China

11-50

www.neologicsbio.com

Biotechnology

Oncology

Therapeutics

Funding Rounds

Corporate Round

OBF

obfuscation

Key People

Xin Dong: Founder and CEO
Baiyang Wang: Founder & SVP

Details

Legal Name

Neologics Bioscience, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Baiyang Wang, Xin Dong

About the Company

Neologics Bioscience is a clinical-stage biotechnology company focusing on developing antibody-based therapeutics for cancer and autoimmune diseases. The company has a pipeline that includes several promising candidates such as NB002, NB003, NB005, and NB303, all targeting solid tumors. Established in 2019, Neologics Bioscience aims to advance its

therapeutic assets through rigorous preclinical and clinical trials to address unmet medical needs in oncology and immunology.

Contact Email

infosuz@neologicsbio.com

Predictions & Insights

Growth Insight

See this Growth Insight

Neologics Bioscience is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

NB001

A fully humanized anti-B7H3 monoclonal antibody designed for tumor cell killing using antibody-drug conjugate modality.

NB002

A fully humanized, Fc-engineered anti-Tim3 monoclonal antibody with unique binding and functional properties distinct from competitors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round
obfuscated obfuscation	Corporate Round - Neologics Bioscience	1	obfuscated obfuscation	WORK Medical Technology Group	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
WORK Medical Technology Group	Yes	Corporate Round - Neologics Bioscience	—
WORK Medical Technology Group	Yes	Corporate Round - Neologics Bioscience	—
WORK Medical Technology Group	Yes	Corporate Round - Neologics Bioscience	—
WORK Medical Technology Group	Yes	Corporate Round - Neologics Bioscience	—
WORK Medical Technology Group	Yes	Corporate Round - Neologics Bioscience	—